Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy: the need for reconsideration

L Rosenberg1

  • 1Slone Epidemiology Unit, Boston University School of Medicine, Brookline, MA 02146.

American Journal of Public Health
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occupational therapy practices among unemployed people in Finland.

Scandinavian journal of occupational therapy·2025
Same author

[Unclear chest pain in a 20-year-old].

Der Internist·2020
Same author

The impact of electrical injuries on long-term outcomes: A Burn Model System National Database study.

Burns : journal of the International Society for Burn Injuries·2019
Same author

The entity of thermal-crush-avulsion hand injury (hot-press roller burns) treated with fast acting debriding enzymes (nexobrid): literature review and report of first case.

Annals of burns and fire disasters·2018
Same author

Bromelain-based enzymatic debridement and minimal invasive modality (mim) care of deeply burned hands.

Annals of burns and fire disasters·2018
Same author

Response to Letter to the Editor: 'Experience with NexoBrid<sup>®</sup> in enzymatic debridement of facial burns'.

Burns : journal of the International Society for Burn Injuries·2018

Millions of menopausal women use hormone supplements. Research is needed to clarify risks and benefits, especially regarding cardiovascular health and cancer, and explore safer alternatives.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Oncology

Background:

  • Millions of menopausal women use hormone supplements, primarily unopposed estrogens.
  • Observational studies suggest potential benefits (reduced cardiovascular disease, fractures) and risks (endometrial, possibly breast cancer).
  • Lack of randomized trial data limits understanding of true effects and confounding factors.

Purpose of the Study:

  • To evaluate the cardiovascular and cancer risks associated with hormone replacement therapy (HRT).
  • To investigate the unknown effects of estrogen combined with progestin on the cardiovascular system.
  • To explore alternative strategies for maintaining cardiovascular and skeletal health without increasing cancer risk.

Main Methods:

  • Review of observational studies on unopposed estrogen use.

Related Experiment Videos

  • Analysis of potential risks and benefits of estrogen-progestin therapy.
  • Discussion of limitations in current understanding and the need for further research.

    • Main Results:

    • Uncertainty exists regarding the true cardiovascular benefits of unopposed estrogens due to healthier user bias.
    • The cardiovascular effects of estrogen-progestin regimens are unknown and may elevate breast cancer risk.
    • Current approaches focusing on single causes or organ systems are insufficient.

    Conclusions:

    • A reconsideration of hormone supplement use in menopausal women is necessary.
    • Alternative health strategies that mitigate cancer risk while improving cardiovascular and skeletal health should be prioritized.
    • More robust research, including randomized trials, is required to guide HRT decisions.